Quick Answer
ACCENDRA HEALTH INC/VA/ reported Stockholders Equity of -$460.98 million for the year ending 2025.
- ACCENDRA HEALTH INC/VA/ showed a decrease of -178.6% in Stockholders Equity from 2024 to 2025.
- This data is from ACCENDRA HEALTH INC/VA/'s annual report (Form 10-K), filed with the SEC on February 20, 2026.
- XBRL data for this metric is available from 2007 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2009: $714.21 million | Q3 2009: $745.50 million | Q4 2009: $769.18 million | Q1 2010: $792.50 million | Q2 2010: $815.53 million | Q3 2010: $837.09 million | Q1 2011: $880.69 million | Q2 2011: $895.78 million | Q3 2011: $906.98 million | Q1 2012: $934.80 million | Q2 2012: $948.83 million | Q3 2012: $958.93 million | Q1 2013: $976.42 million | Q2 2013: $988.69 million | Q3 2013: $1.01 billion | Q1 2014: $1.03 billion | Q2 2014: $1.03 billion | Q3 2014: $1.01 billion | Q4 2016: $960.04 million | Q2 2017: $993.57 million | Q3 2017: $1.00 billion | Q2 2018: $802.21 million | Q3 2018: $792.41 million | Q1 2019: $501.84 million | Q2 2019: $496.90 million | Q3 2019: $491.28 million | Q1 2020: $416.34 million | Q2 2020: $395.16 million | Q3 2020: $451.34 million | Q1 2021: $786.26 million | Q2 2021: $848.02 million | Q3 2021: $887.01 million | Q1 2022: $947.62 million | Q2 2022: $958.66 million | Q3 2022: $966.84 million | Q1 2023: $924.40 million | Q2 2023: $896.23 million | Q3 2023: $886.86 million | Q1 2024: $916.01 million | Q2 2024: $881.84 million | Q3 2024: $895.73 million | Q1 2025: $570.98 million | Q2 2025: -$281.01 million | Q3 2025: -$429.51 million.
- Over the full 17 years of available data (2007 to 2025), ACCENDRA HEALTH INC/VA/'s Stockholders Equity has declined by 175.0%.
- Historical annual values: Fiscal year 2025: -$460.98 million | Fiscal year 2024: $586.36 million | Fiscal year 2023: $945.30 million | Fiscal year 2022: $966.74 million | Fiscal year 2021: $938.50 million | Fiscal year 2020: $712.05 million | Fiscal year 2019: $462.15 million | Fiscal year 2018: $518.42 million | Fiscal year 2017: $1.02 billion | Fiscal year 2014: $990.84 million | Fiscal year 2013: $1.02 billion | Fiscal year 2012: $972.53 million | Fiscal year 2011: $918.09 million | Fiscal year 2010: $857.52 million | Fiscal year 2009: $769.18 million | Fiscal year 2008: $689.05 million | Fiscal year 2007: $614.36 million.
- Data sourced from SEC EDGAR public filings as of August 4, 2026.
Last verified: